Insider · CIK 0001640575
Kelly Blackburn
Files at CRVO (CervoMed Inc.). First filing -, latest -.
In brief
Kelly Blackburn files SEC Form 4 as officer at CRVO (CervoMed Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kelly Blackburn has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Feb 13, 2026 |
| Feb 4, 2025 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +27,000 | $0.00 | $0 | 27,000 | Feb 14, 2025 |
| Jan 26, 2024 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jan 26, 2024 |
Questions about Kelly Blackburn
Answered from the filings on this page, as of the latest one.
Is Kelly Blackburn buying or selling?
Kelly Blackburn has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kelly Blackburn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kelly Blackburn has 0.
Where does Kelly Blackburn file Form 4?
Kelly Blackburn has filed Form 4 at CRVO (CervoMed Inc.) as SVP, Clinical Development. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.